GLP-1 Meds for Weight Loss was built by clinicians, researchers, and patient advocates who were frustrated by the noise — the ads disguised as reviews, the fear-mongering, and the confusing jargon. We set out to fix that.
To be the most trustworthy independent source of GLP-1 information on the internet — written in plain language, backed by clinical evidence, and never influenced by the brands we cover.
We cover everything from how GLP-1 receptor agonists work biologically, to honest head-to-head product comparisons, to practical guidance on side effects, nutrition, and navigating insurance. If a patient or caregiver has a question about GLP-1 medications, our goal is to have the best answer — and to show our work.
When GLP-1 medications became a cultural phenomenon in 2023, the internet was not ready. Search results were flooded with brand-sponsored listicles, forum speculation, and scare-tactic headlines — none of it written by people who actually understood the science or had sat with patients navigating these decisions.
This site was started by a small group of people who had firsthand experience with that gap — clinically, journalistically, and personally. Some of us had prescribed these medications for years and watched patients arrive armed with misinformation. Some of us had been those patients. All of us believed the same thing: a well-informed patient makes better decisions, and better decisions lead to better outcomes.
We built this site to be the resource we wished had existed — thorough, honest, sourced, and written in language that doesn't require a medical degree to understand. Three years later, over 100,000 people read it every month. We're proud of that, and we take the responsibility seriously.
GLP-1 searches explode online. Misinformation, sponsored content, and fear-mongering dominate results. A gap in trustworthy patient-facing content becomes impossible to ignore.
A small team begins publishing clinically reviewed, independently researched GLP-1 guides — with a hard rule against pharmaceutical sponsorship baked in from day one.
A rigorous multi-step editorial review process is established, with every article requiring sign-off from a qualified medical reviewer before publication.
Readership crosses 100k per month. The product review program launches with full affiliate disclosure on every page — no exceptions.
Relaunched on a dedicated domain with expanded coverage of telehealth platforms, insurance navigation, compounding regulations, and the latest clinical research.
Every article, review, and guide we publish is built on these six principles. They aren't guidelines — they're non-negotiables.
Every clinical claim is sourced to peer-reviewed research, FDA documentation, or official trial data. We cite our sources — always. If we can't find solid evidence for something, we say so.
We do not accept advertising, sponsored content, or payments of any kind from pharmaceutical manufacturers. Our revenue comes solely from disclosed affiliate commissions when readers sign up for telehealth platforms we review.
Every article is reviewed by at least one licensed medical professional before publication. Complex clinical topics are reviewed by relevant specialists — endocrinologists for metabolic content, cardiologists for cardiovascular claims.
The GLP-1 landscape moves fast. We audit our highest-traffic pages monthly and update them whenever new trial data, FDA guidance, or market changes require it. Every page shows its last-reviewed date.
We write for curious, intelligent adults — not for academic journals. Medical accuracy and plain language aren't in conflict. We define every piece of jargon we use and never hide behind complexity.
Affiliate relationships, potential conflicts of interest, and the basis of our opinions are disclosed on every page that requires it. We believe transparency isn't just ethical — it's what makes us worth reading.
Every piece of content — from a 200-word FAQ answer to a 5,000-word product review — goes through the same rigorous process before it reaches you. Here's exactly what that looks like.
No article on this site has ever been written, edited, or influenced at the direction of a brand, advertiser, or pharmaceutical company. Affiliate relationships are disclosed and never affect our ratings or conclusions. This policy is absolute and has no exceptions.
Writers begin with primary sources — clinical trial publications, FDA labeling, peer-reviewed meta-analyses, and official prescribing information. No secondary sources are cited without tracing the original data.
The first draft is produced, then each factual claim is individually fact-checked and linked to its primary source. Statistics, percentages, and clinical outcomes are verified against the original trial data.
A qualified medical reviewer — matched to the topic's specialty — reviews the draft for clinical accuracy, identifies any misleading framing, and approves or requests corrections before publication.
Our patient experience editor reads every piece to ensure it's understandable to a non-clinical reader. Jargon is flagged and simplified. Tone is checked for empathy and clarity.
Before going live, the editor-in-chief confirms all required disclosures are present — affiliate relationships, medical review credits, and last-reviewed dates are visible on every article.
High-traffic pages are reviewed monthly. When new trial data, FDA updates, or pricing changes occur, the article is updated within 72 hours and the modification date is visible to readers.
Our sole revenue source is disclosed affiliate commissions — a small fee paid by telehealth platforms when a reader signs up through our link, at no extra cost to the reader. We earn the same commission regardless of which platform we recommend, so our rankings are never influenced by payout rates.
We do not run display ads, sponsored posts, or native advertising from pharmaceutical manufacturers or their marketing agencies. No Novo Nordisk banner ads. No Eli Lilly sponsored content. This is a hard line we will never cross — it is the foundation of our credibility.
Every product review and comparison article discloses our affiliate relationships at the top of the page, before the reader makes any decision. We also publish a complete list of our affiliate partners on our editorial policy page. Transparency isn't a footnote — it's the headline.
Whether you're a patient with a question, a researcher spotting an error, a journalist seeking comment, or a healthcare provider who wants to collaborate — our inbox is always open.
Our editorial team reads every message. Reader questions that we can't answer individually often become our next article.